Cargando…

The metabolic footprint of the airway bacterial community in cystic fibrosis

BACKGROUND: Progressive, chronic bacterial infection of the airways is a leading cause of death in cystic fibrosis (CF). Culture-independent methods based on sequencing of the bacterial 16S rRNA gene describe a distinct microbial community that decreases in richness and diversity with disease progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayanamurthy, Vaishnavi, Sweetnam, John M., Denner, Darcy R., Chen, Lena W., Naureckas, Edward T., Laxman, Bharathi, White, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493850/
https://www.ncbi.nlm.nih.gov/pubmed/28666467
http://dx.doi.org/10.1186/s40168-017-0289-z
_version_ 1783247577161924608
author Narayanamurthy, Vaishnavi
Sweetnam, John M.
Denner, Darcy R.
Chen, Lena W.
Naureckas, Edward T.
Laxman, Bharathi
White, Steven R.
author_facet Narayanamurthy, Vaishnavi
Sweetnam, John M.
Denner, Darcy R.
Chen, Lena W.
Naureckas, Edward T.
Laxman, Bharathi
White, Steven R.
author_sort Narayanamurthy, Vaishnavi
collection PubMed
description BACKGROUND: Progressive, chronic bacterial infection of the airways is a leading cause of death in cystic fibrosis (CF). Culture-independent methods based on sequencing of the bacterial 16S rRNA gene describe a distinct microbial community that decreases in richness and diversity with disease progression. Understanding the functional characteristics of the microbial community may aid in identifying potential therapies and may assist in management, but current methods are cumbersome. Here, we demonstrate the use of an oxidative metabolic assay as a complement to sequencing methods to describe the microbiome in the airways of patients with CF. METHODS: Expectorated sputum was collected from 16 CF subjects and 8 control subjects. The Biolog Gen III Microplate was used in a community-level physiological profiling (CLPP)-based assay to examine oxidative metabolic activity. 16S rRNA V4 amplicon sequencing was used to characterize the taxonomy and diversity of the samples. Correlations were then identified among the oxidative activity and taxonomy data. In an additional paired analysis, sputum from seven CF subjects were collected at two separate clinic visits and compared for oxidative activity, taxonomy, and diversity. RESULTS: Significant differences in oxidative metabolic activity, microbial taxonomy, and diversity were found between the CF and control sputum samples. Oxidative activity correlated positively with total genera but not with other measures of diversity or taxonomy, demonstrating that the metabolic assay complements the structural aspects of the microbiome. As expected, Pseudomonas was significantly enriched in CF samples, while Streptococcus and Prevotella were similarly abundant in both CF and control samples. Paired analysis of CF samples at separate clinic visits revealed comparable oxidative activity that correlated with similar stability in taxonomy and diversity. CONCLUSIONS: The CLPP assay used in this study complements existing sequencing methods to delineate the oxidative metabolic footprint of the CF airway bacterial community. This method may be useful to study the CF microbial community over time and with changes in disease state. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-017-0289-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5493850
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54938502017-07-05 The metabolic footprint of the airway bacterial community in cystic fibrosis Narayanamurthy, Vaishnavi Sweetnam, John M. Denner, Darcy R. Chen, Lena W. Naureckas, Edward T. Laxman, Bharathi White, Steven R. Microbiome Short Report BACKGROUND: Progressive, chronic bacterial infection of the airways is a leading cause of death in cystic fibrosis (CF). Culture-independent methods based on sequencing of the bacterial 16S rRNA gene describe a distinct microbial community that decreases in richness and diversity with disease progression. Understanding the functional characteristics of the microbial community may aid in identifying potential therapies and may assist in management, but current methods are cumbersome. Here, we demonstrate the use of an oxidative metabolic assay as a complement to sequencing methods to describe the microbiome in the airways of patients with CF. METHODS: Expectorated sputum was collected from 16 CF subjects and 8 control subjects. The Biolog Gen III Microplate was used in a community-level physiological profiling (CLPP)-based assay to examine oxidative metabolic activity. 16S rRNA V4 amplicon sequencing was used to characterize the taxonomy and diversity of the samples. Correlations were then identified among the oxidative activity and taxonomy data. In an additional paired analysis, sputum from seven CF subjects were collected at two separate clinic visits and compared for oxidative activity, taxonomy, and diversity. RESULTS: Significant differences in oxidative metabolic activity, microbial taxonomy, and diversity were found between the CF and control sputum samples. Oxidative activity correlated positively with total genera but not with other measures of diversity or taxonomy, demonstrating that the metabolic assay complements the structural aspects of the microbiome. As expected, Pseudomonas was significantly enriched in CF samples, while Streptococcus and Prevotella were similarly abundant in both CF and control samples. Paired analysis of CF samples at separate clinic visits revealed comparable oxidative activity that correlated with similar stability in taxonomy and diversity. CONCLUSIONS: The CLPP assay used in this study complements existing sequencing methods to delineate the oxidative metabolic footprint of the CF airway bacterial community. This method may be useful to study the CF microbial community over time and with changes in disease state. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-017-0289-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-30 /pmc/articles/PMC5493850/ /pubmed/28666467 http://dx.doi.org/10.1186/s40168-017-0289-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Narayanamurthy, Vaishnavi
Sweetnam, John M.
Denner, Darcy R.
Chen, Lena W.
Naureckas, Edward T.
Laxman, Bharathi
White, Steven R.
The metabolic footprint of the airway bacterial community in cystic fibrosis
title The metabolic footprint of the airway bacterial community in cystic fibrosis
title_full The metabolic footprint of the airway bacterial community in cystic fibrosis
title_fullStr The metabolic footprint of the airway bacterial community in cystic fibrosis
title_full_unstemmed The metabolic footprint of the airway bacterial community in cystic fibrosis
title_short The metabolic footprint of the airway bacterial community in cystic fibrosis
title_sort metabolic footprint of the airway bacterial community in cystic fibrosis
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493850/
https://www.ncbi.nlm.nih.gov/pubmed/28666467
http://dx.doi.org/10.1186/s40168-017-0289-z
work_keys_str_mv AT narayanamurthyvaishnavi themetabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT sweetnamjohnm themetabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT dennerdarcyr themetabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT chenlenaw themetabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT naureckasedwardt themetabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT laxmanbharathi themetabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT whitestevenr themetabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT narayanamurthyvaishnavi metabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT sweetnamjohnm metabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT dennerdarcyr metabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT chenlenaw metabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT naureckasedwardt metabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT laxmanbharathi metabolicfootprintoftheairwaybacterialcommunityincysticfibrosis
AT whitestevenr metabolicfootprintoftheairwaybacterialcommunityincysticfibrosis